(805) 483 1185

English
Español
01 Fomat_Logo_Website-min
  • Home
  • Join a Trial
    • Join a Trial
    • Healthy Volunteers
    • Participant Stories
  • Sponsors
    • Phase I Capabilities
    • Phase II- IV Capabilities
    • Diversity
  • About Us
    • About Us
    • Our Investigators
    • Careers
    • Diversity
  • Resources
    • Company Updates
    • Blogs & Updates
    • Events and Conferences
  • Contact FOMAT

Home » propranolol

Posts tagged: propranolol

Propranolol anti-cancer properties

Researchers: It’s Time to Consider Propranolol as Anti-Cancer Drug

October 14, 2016
by Beatriz Morales

Propranolol, a beta-blocker commonly prescribed to treat irregular heart rates and other conditions, has significant anti-cancer properties, say researchers in a new clinical study published in ecancermedicalscience. The Repurposing Drugs in Oncol ...

Read More
0

Contact Us

    Upcoming Events

    Global SCRS

    Sep 29 - Oct 1, 2025

    Orlando, FL

    AAO 2025​

    Oct 18-20, 2025​

    Orlando, FL

    ACG 2025​

    Oct 24-29, 2025

    Chicago, IL

    Full Event List
    • Review us on Google
    • Review us on Yelp

    Conditions & Theraputic Areas

    Join a Trial

    Healthy Volunteers

    Sponsors

    Phase I Capabilities

    Phase II & III Capabilities

    Diversity

    About Us

    Careers

    Investigators

    Contact Us

    • Review us on Google
    • Review us on Yelp

    Contact Us

    FOMAT Medical Research INC,
    300 South A Street Suite 201 Oxnard, CA 93030
    (805) 483 1185
    Trials Information: [email protected]
    General Information: [email protected]

    Contact Us

    FOMAT Medical Research INC,
    300 South A Street Suite 201 Oxnard, CA 93030
    (805) 483 1185
    Trials Information: [email protected]
    General Information: [email protected]
    • Review us on Google
    • Review us on Yelp
    Proud Partner of hyperCORE
    Facebook Linkedin Instagram
    Shopping Basket
    We use cookies to ensure the best possible experience on our website. By continuing to use this site, we will assume that you are happy with itAcceptPrivacy policy